Advertisements

Panadol Actifast

Quick links to important sections

Panadol Actifast

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Panadol Actifast

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Form Oral tablet/caplet
Pharmacological Class Non-opioid analgesic and antipyretic
Origin Synthetic compound
Key Differentiating Feature Accelerated absorption formulation

Panadol Actifast: A Specialized Analgesic for Rapid Relief

Panadol Actifast is a non-prescription analgesic and antipyretic medication formulated for the quick relief of common mild to moderate pain and fever. It is positioned as a fast-acting solution designed to accelerate the onset of action compared to standard formulations of the drug.

Its core role is to serve as an effective pain and fever reliever. The formulation is intentionally developed to dissolve and be absorbed faster, aligning with its key characteristic of providing prompt relief.


Composition and Pharmacological Classification

The single Active Pharmaceutical Ingredient (API) contained in Panadol Actifast is paracetamol (also known as acetaminophen). This compound is a synthetically produced agent that is classified pharmacologically as a non-opioid analgesic and antipyretic.

This pharmaceutical agent functions by reducing pain and fever without the use of opioid components. Panadol Actifast uses this well-established API in a dose-optimized form to target the rapid relief of symptoms.


Form and Accelerated Formulation Technology

Panadol Actifast is supplied as an oral tablet that utilizes advanced technology to accelerate drug delivery. The unique aspect of this specific formulation is the inclusion of specialized excipients, notably sodium bicarbonate, which aids in its rapid action.

This component helps to speed up the tablet’s disintegration and dissolution in the stomach. This mechanism makes the paracetamol available for absorption into the bloodstream sooner than conventional tablets, which is the foundational principle behind the product's fast-acting nature.

Regulatory References

  1. recognized by major health organizations
  2. U.S. National Institutes of Health (NIH)
  3. MedlinePlus, NIH
Advertisements

What side effects are possible with Panadol Actifast?

Possible side effects and safety information

The safety profile of the active ingredient in Panadol Actifast, paracetamol (acetaminophen), is extensively documented by global regulatory authorities. Safety information is organized according to the frequency and body system affected, as detailed in official prescribing information.


Classification of Officially Listed Adverse Reactions

Adverse reactions are formally categorized into frequency tiers by regulatory agencies, such as the EMA and FDA. For this active ingredient, the most critical events are classified as having a very low statistical incidence:

  • Rare Reactions (Affecting 1 to 10 users in 10,000): Documented effects related to the Hepatobiliary System, including the observation of abnormal liver function tests.
  • Very Rare Reactions (Affecting fewer than 1 user in 10,000): This tier includes serious adverse reactions affecting multiple systems:
    • Blood and Lymphatic System: Reactions such as thrombocytopenia (a decrease in platelets) and agranulocytosis (a severe reduction in white blood cells).
    • Immune System and Skin: Severe hypersensitivity reactions like anaphylaxis and life-threatening dermatological events, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Critical Safety Considerations and Constraints

The primary safety constraint is the potential for hepatotoxicity (liver damage). Regulatory notes emphasize that the risk of severe liver damage is associated with exceeding official dosage recommendations or chronic misuse. This risk is compounded by co-existing conditions, leading to specific constraints:

  • Severe Hepatic Impairment: The drug is contraindicated in individuals with severe hepatic insufficiency or decompensated active liver disease.
  • Renal Impairment: Caution is noted for patients with severe kidney issues due to potential metabolite accumulation.
  • Interaction Risk: Official safety texts warn of an increased risk of liver injury when used for prolonged periods with certain hepatic enzyme-inducing medicines.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Suspected overdose of the active ingredient in Panadol Actifast, paracetamol (acetaminophen), requires immediate attention, as documented in official regulatory sources. The official profile emphasizes the potential for delayed, life-threatening organ damage.

Documented Overdose Manifestations and Risks

Initial signs of overdose are often mild or non-specific, potentially limited to pallor, nausea, vomiting, and abdominal pain. Critically, these early symptoms may not reflect the severity of the underlying toxicity. The primary and most serious risk associated with overdose is severe, delayed hepatic injury, which may progress to acute liver failure, encephalopathy, and death. Acute renal failure, metabolic acidosis, and cardiac arrhythmias are also documented severe outcomes. Risk of liver damage is greater in individuals with pre-existing hepatic impairment, chronic malnutrition, or those taking certain enzyme-inducing drugs.

Mandatory Emergency Actions

Immediate medical advice must be sought in the event of a suspected overdose, even if the patient feels well. Patients must be referred to a hospital urgently for immediate medical attention. The effective antidote, N-acetylcysteine, is available and its administration is time-dependent. Plasma paracetamol concentration must be measured at four hours or later post-ingestion to guide clinical management, which should also include symptomatic and supportive measures.

Advertisements

Therapeutic Uses of Panadol Actifast

What Panadol Actifast Treats: Main Uses and Benefits

This medication is primarily relevant for easing symptoms related to mild to moderate pain and fever, offering temporary assistance when symptoms interfere with normal stability. The active component is utilized for these indications to provide relief and reduce febrile states.

It is considered relevant for easing symptoms related to physical discomfort, such as tension headaches, toothache, backache, muscular aches, and the acute pain associated with menstrual periods. It is applied in addressing symptoms related to systemic imbalance, including fever and generalized body aches that often accompany colds and influenza. This support may assist with maintaining functional stability and contributes to easing the overall symptom load.

“Applied across domains where additional symptomatic support is needed, this medicine assists with maintaining functional stability when symptoms are more noticeable.”

This supportive relief is relevant when short-term symptomatic assistance is needed, such as in clinical contexts following immunization or discomfort after minor dental procedures. The product is applied when appropriate for situations requiring short-term symptomatic assistance, and contributes to easing the overall symptom load.


Quick Fact: Relief for Acute Discomfort The product is relevant for easing acute and episodic pain and febrile states, offering supportive symptom management when symptoms appear suddenly or intensify temporarily.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Profile

The eligibility profile for Panadol Actifast (Paracetamol/Acetaminophen with Sodium Bicarbonate) is defined by official regulatory documents, strictly classifying allowed, restricted, and prohibited populations.

Age-Related Eligibility

The product is intended for adults and adolescents aged 12 years and over. Use is not recommended for children under 12 years of age. Older adults are generally permitted the standard dose, but those who are frail or have underlying organ impairment may require restricted use.

Contraindications and Restrictions

Classification Population Entity
Contraindicated Hypersensitivity to paracetamol or any excipient.
Contraindicated Individuals taking any other paracetamol-containing products concurrently.
Restricted Use Patients with impaired hepatic or renal function.
Conditional Use Patients on a sodium-controlled diet (must account for high sodium content).
Caution Advised Patients who are glutathione deplete (e.g., severe malnutrition, chronic alcoholism, or severe infection) [1.2].
Conditional Use Pregnant women (permitted if clinically needed, using the lowest effective dose for the shortest possible time).
Permitted Use Breastfeeding women (use is not contra-indicated at therapeutic doses).
Advertisements

What should I know about interactions with other medicines?

The official interaction profile for Panadol Actifast is defined by its active component, paracetamol (acetaminophen), and requires adherence to strict regulatory constraints. Co-administration with any other product containing paracetamol is formally restricted due to the severe risk of overdose and potential liver failure.

Pharmacodynamic and Metabolic Interactions

Interactions affecting coagulation include warfarin and other coumarins, where prolonged regular daily use may enhance the anticoagulant effect, which is documented as increasing the risk of bleeding. Metabolic interactions involve agents that induce hepatic enzymes—specifically carbamazepine, phenytoin, rifampicin, and the herbal product St John's Wort—which increase the hazard of paracetamol-related liver damage, particularly with misuse. Other medicines like probenecid are documented to impair paracetamol's clearance, raising plasma concentrations.

Pharmacokinetic and Timing Constraints

The speed of absorption is officially documented to be increased by metoclopramide or domperidone and reduced by cholestyramine. Due to this reduction, administration is generally recommended to be separated by at least one hour from cholestyramine. Caution is also advised during co-administration with flucloxacillin due to reported association with high anion gap metabolic imbalance.

Substance and Population Restrictions

A substance restriction applies to alcohol; chronic consumption of three or more alcoholic drinks per day is officially associated with an increased risk of severe liver damage. Furthermore, due to the high sodium content of the formulation’s excipient, the product is restricted for use by patients following a low sodium diet.

Advertisements

Mechanism of Action

How Panadol Actifast Works

Accelerated Absorption Mechanism The paracetamol formulation is designed for rapid systemic absorption. It incorporates components that accelerate the rate of paracetamol uptake from the gastrointestinal tract, facilitating the swift initiation of systemic action.

Central Nervous System (CNS) Activity Paracetamol acts primarily via selective inhibition of cyclooxygenase (COX) activity within the central nervous system (CNS), which reduces the synthesis of prostaglandins. This decrease in central prostaglandin synthesis functions to modulate nociceptive pathways.

Hypothalamic Cascade The mechanism also includes an antipyretic effect. This is mediated by the action of paracetamol on the hypothalamic heat-regulating center, affecting the set-point and downstream processes of thermoregulation.

Advertisements

Dosage and Administration Information

Panadol Actifast is administered exclusively via the oral route, utilizing the standard 500 mg paracetamol tablet strength. Established usage parameters provide clear constraints on the amount and frequency of intake to ensure proper consumption and to maximize the intended accelerated absorption.

The standard unit dose for adults and adolescents aged 16 years and over is one or two tablets, corresponding to 500 mg to 1000 mg of paracetamol per administration. The maximum daily dose is strictly limited to 8 tablets (4000 mg) in any 24-hour period. Administration must be spaced by a minimum interval of four hours and should not exceed four doses per day. The duration of use is generally confined to short-term symptomatic management and should not exceed 3 consecutive days without professional guidance. For optimal speed of action, the tablets are generally recommended to be taken on an empty stomach.

Population-Specific Usage Principles

Dosage modifications are defined for younger individuals. Children aged 10 to 15 years are prescribed one 500 mg tablet per dose, with the maximum total intake restricted to four tablets in a 24-hour period. Use is generally not recommended for children under 10 years of age.

In the context of pre-existing conditions, individuals with severe renal or hepatic impairment are directed to seek medical advice regarding dose adjustment or interval prolongation, as standard regimens may not apply.

Classification Instruction
Route of Administration Oral administration.
Minimum Dosing Interval 4 hours.
Use-Context Constraint Prohibited for use alongside any other paracetamol-containing product.
Advertisements

Recent Clinical Evidence

Research Evidence for Pain Management

Research exploring the specific Panadol Actifast formulation has mainly been conducted through short-term, controlled studies. These studies primarily focus on how rapidly the paracetamol component is absorbed into the body, and how this absorption rate was evaluated regarding initial symptom patterns. This research was evaluated in adult populations experiencing acute, episodic pain, such as headaches or pain after dental procedures. Patient-reported outcomes describing perceived discomfort and the timing of the first measured change in sensation were the key areas monitored.

Research examined how the specific formulation in Actifast, which includes sodium bicarbonate, was associated with patterns of more rapid absorption in the bloodstream when compared against non-buffered formulations in certain trials. Research highlights measurements concerning the initial timing of a reported change in physical discomfort. The findings contribute to understanding symptom patterns over short time intervals, specifically within the first few hours after a single dose.


Research Evidence for Studies Examining Fever Patterns

Research has explored Panadol Actifast in scenarios involving symptomatic outcomes related to systemic or functional imbalance when the condition involves fever. Research examined temporary physiological imbalance by monitoring outcomes related to body temperature changes. Studies focused on episodes where symptoms become more noticeable, such as when a person is experiencing a febrile state.

Data are still emerging regarding the physiological axes studied for this specific formulation. Comparative evidence is lacking for studies that solely focused on temperature change outcomes when examining different treatments. Evidence is limited in detailing whether the described patterns of temperature change are sustained over a full dosing interval or how they vary based on the underlying cause of the fever.


Long-Term Research and Durability of Findings

Most of the available evidence comes from studies observing responses over defined time intervals (typically 4 to 8 hours) that explore acute changes in physical discomfort. However, long-term outcomes are not fully established regarding the specific changes associated with long-term use of the Panadol Actifast formulation. There is limited information for long-term outcomes that monitor outcomes reflecting daily functioning or activity level over extended periods.


Areas Where Research Remains Incomplete

The core evidence for Panadol Actifast was evaluated in Randomized Controlled Trials (RCTs), and research examined the studies exploring how symptoms change over time. However, the evidence quality varies across studies, and research often focuses narrowly on the initial absorption patterns. Comparative evidence is lacking for several common pain and fever scenarios, and data for certain groups remain insufficient regarding the presence of specific comorbidities. The results apply only to the populations studied in the primary trials.

Key Studies & References

  1. Efficacy and speed of onset of an effervescent paracetamol preparation in acute pain: a systematic review and meta-analysis of randomized controlled trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Panadol Actifast (FAQ)


Q: Is Panadol Actifast the same as regular Panadol?

Regulatory documents describe Panadol Actifast as containing the same active ingredient, paracetamol (acetaminophen), as standard Panadol. The difference is the specialized formulation, which includes sodium bicarbonate as a key excipient. This addition is described as accelerating the tablet’s absorption compared to non-buffered versions.


Q: What types of pain is Panadol Actifast typically used for?

According to the official product information, this medicine is indicated for the temporary relief of mild to moderate pain. Official documents indicate that the medicine is used for common discomforts such as headache, toothache, and muscle aches, as well as for relieving cold and flu symptoms.


Q: How quickly is Panadol Actifast expected to start working?

Studies and official information indicate that the formulation is designed for accelerated absorption into the body. Research reviewed in official sources focuses on the initial timing of a reported change in discomfort, which aligns with the specialized formulation’s faster absorption pattern.


Q: What is the difference between Panadol Actifast and paracetamol tablets?

The core difference is the inclusion of the excipient sodium bicarbonate. Regulatory texts describe this component as modifying the tablet to achieve faster dissolution and absorption of the paracetamol active ingredient in the digestive system.


Q: Are there any common side effects listed for Panadol Actifast?

Official regulatory documents categorize adverse reactions by how often they occur. While serious reactions are classified as rare, the most frequently reported effects for paracetamol formulations in official lists often include nausea and vomiting.


Q: Can Panadol Actifast be taken with food?

Regulatory guidance suggests that for the fastest onset of action, the tablets are generally recommended to be taken on an empty stomach. Taking the medicine with food may affect the rate of absorption, which regulatory information indicates can reduce or delay its rapid action.


Q: What should be done if someone accidentally takes more than the recommended amount?

Official documents explicitly warn that in the event of an overdose, immediate medical attention should be sought, even if a person has no symptoms. This is due to the potential risk of delayed, severe liver damage associated with exceeding the recommended dosage.


Q: Can people with high blood pressure use Panadol Actifast, given the sodium content?

Official regulatory warnings note that the formulation contains sodium bicarbonate. Patients who are following a sodium-controlled diet or those who need to restrict their sodium intake must take the product’s sodium content into account.


Q: Can the fast-acting property of the drug affect its duration?

Official texts describe the product as being formulated for a faster time to reach maximum concentration in the bloodstream. However, the minimum recommended interval for taking the next dose remains four hours, suggesting the overall duration of effect aligns with this interval.


Q: Is Panadol Actifast available over-the-counter?

In many regulatory jurisdictions, this product is officially classified as a non-prescription (over-the-counter) medicine. It is intended for consumer self-care without a mandatory doctor’s prescription.


Q: What happens if I miss a scheduled time for the next dose?

Official guidelines state that if a dose is missed, the person should take the next dose when it is due. It is important to ensure the minimum interval of four hours between administrations is respected before taking the next dose.


Q: Is there a risk of dependency or addiction with Panadol Actifast?

Regulatory documents classify the active ingredient, paracetamol, as a non-opioid analgesic. Official product information does not list dependency or addiction as a risk associated with the therapeutic use of this medicine.


Q: Can Panadol Actifast be crushed or split?

Official product information describes the intended method of use as swallowing the tablets whole. The label does not provide instructions for crushing or splitting, and doing so may impact the intended performance of the specialized, rapid-absorption formulation.


Q: Does Panadol Actifast cause drowsiness?

Official regulatory lists of known side effects for this paracetamol formulation do not commonly include drowsiness or sleepiness. Therefore, it is generally not listed as an expected side effect.


Q: Are there any specific official warnings for people with heart conditions?

Official warnings mention the sodium content of the formulation due to the inclusion of sodium bicarbonate. Patients with cardiac conditions who have been advised to follow a sodium-restricted diet are advised to take this content into consideration.


Q: Is Panadol Actifast available as a liquid or syrup?

The official product documentation and descriptions consistently describe Panadol Actifast as being available in the form of an oral tablet or caplet.


Q: Does the 'Actifast' formulation change the side effect profile compared to standard paracetamol?

Official regulatory documents list the side effects primarily based on the active ingredient, paracetamol. The main difference noted is the presence of the excipient sodium bicarbonate, which can introduce sodium-related effects that may need to be considered by certain populations.


Q: Is Panadol Actifast a brand name for a generic medicine?

Panadol Actifast is regulated as a brand name product. Its active component, paracetamol (also known as acetaminophen), is a generic substance that is widely available in many other medicinal products.


Q: Can I take Panadol Actifast if I have stomach ulcers?

Official warnings mainly focus on liver and kidney impairment. Unlike some other pain relievers, paracetamol is not listed with a primary contraindication related to stomach ulcers.

Advertisements

How should Panadol Actifast be stored and disposed of?

How to Store and Dispose of Panadol Actifast

The storage and disposal instructions for Panadol Actifast are derived from official regulatory labeling to maintain product quality and safety.

Storage Requirements

Constraint Official Requirement
Temperature Do not store above 25°C.
Child Safety Keep out of the sight and reach of children.
Packaging Must remain in the original container (blister pack).
Stability Do not use the medicine after the expiration date ('EXP').

Disposal Instructions

Unused or expired Panadol Actifast should be returned to a pharmacist for proper disposal, in accordance with regulatory guidance. It is specified that the product must not be disposed of via wastewater or placed in household refuse to protect the environment. These constraints ensure the medication is handled safely from packaging to final discard.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadol Actifast found in:

A-Z Index: